124 related articles for article (PubMed ID: 34499901)
1. Activin A Sustains the Metastatic Phenotype of Tumor-Associated Macrophages and Is a Prognostic Marker in Human Cutaneous Melanoma.
Gutiérrez-Seijo A; García-Martínez E; Barrio-Alonso C; Parra-Blanco V; Avilés-Izquierdo JA; Sánchez-Mateos P; Samaniego R
J Invest Dermatol; 2022 Mar; 142(3 Pt A):653-661.e2. PubMed ID: 34499901
[TBL] [Abstract][Full Text] [Related]
2. Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion.
Donovan P; Dubey OA; Kallioinen S; Rogers KW; Muehlethaler K; Müller P; Rimoldi D; Constam DB
J Invest Dermatol; 2017 Dec; 137(12):2578-2587. PubMed ID: 28844941
[TBL] [Abstract][Full Text] [Related]
3. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.
Fujimura T; Aiba S
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32707850
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
5. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
[TBL] [Abstract][Full Text] [Related]
6. Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages.
Di Martile M; Farini V; Consonni FM; Trisciuoglio D; Desideri M; Valentini E; D'Aguanno S; Tupone MG; Buglioni S; Ercolani C; Gallo E; Amadio B; Terrenato I; Foddai ML; Sica A; Del Bufalo D
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32269145
[TBL] [Abstract][Full Text] [Related]
7. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma.
Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP
Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106
[TBL] [Abstract][Full Text] [Related]
8. A MyD88/IL1R Axis Regulates PD-1 Expression on Tumor-Associated Macrophages and Sustains Their Immunosuppressive Function in Melanoma.
Tartey S; Neale G; Vogel P; Malireddi RKS; Kanneganti TD
Cancer Res; 2021 May; 81(9):2358-2372. PubMed ID: 33619117
[TBL] [Abstract][Full Text] [Related]
9. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors.
Massi D; Marconi C; Franchi A; Bianchini F; Paglierani M; Ketabchi S; Miracco C; Santucci M; Calorini L
Hum Pathol; 2007 Oct; 38(10):1516-25. PubMed ID: 17640716
[TBL] [Abstract][Full Text] [Related]
10. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of anti-tumor immunity by melanoma cell-derived Activin-A depends on STING.
Pinjusic K; Ambrosini G; Lourenco J; Fournier N; Iseli C; Guex N; Egorova O; Nassiri S; Constam DB
Front Immunol; 2023; 14():1335207. PubMed ID: 38304252
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression.
Bianchini F; Massi D; Marconi C; Franchi A; Baroni G; Santucci M; Mannini A; Mugnai G; Calorini L
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):320-8. PubMed ID: 17499752
[TBL] [Abstract][Full Text] [Related]
13. FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.
Yang JB; Zhao ZB; Liu QZ; Hu TD; Long J; Yan K; Lian ZX
Oncogene; 2018 Mar; 37(9):1192-1204. PubMed ID: 29238041
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophages: from basic research to clinical application.
Yang L; Zhang Y
J Hematol Oncol; 2017 Feb; 10(1):58. PubMed ID: 28241846
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.
Chen P; Huang Y; Bong R; Ding Y; Song N; Wang X; Song X; Luo Y
Clin Cancer Res; 2011 Dec; 17(23):7230-9. PubMed ID: 21994414
[TBL] [Abstract][Full Text] [Related]
16. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.
Fujimura T; Kakizaki A; Furudate S; Kambayashi Y; Aiba S
J Dermatol Sci; 2016 Sep; 83(3):167-73. PubMed ID: 27291068
[TBL] [Abstract][Full Text] [Related]
18. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-derived conditioned media efficiently induce the differentiation of monocytes to macrophages that display a highly invasive gene signature.
Wang T; Ge Y; Xiao M; Lopez-Coral A; Azuma R; Somasundaram R; Zhang G; Wei Z; Xu X; Rauscher FJ; Herlyn M; Kaufman RE
Pigment Cell Melanoma Res; 2012 Jul; 25(4):493-505. PubMed ID: 22498258
[TBL] [Abstract][Full Text] [Related]
20. Activin-A impedes the establishment of CD4
Morianos I; Tsitsopoulou A; Potaris K; Valakos D; Fari O; Vatsellas G; Bostantzoglou C; Photiades A; Gaga M; Xanthou G; Semitekolou M
J Exp Clin Cancer Res; 2021 Sep; 40(1):295. PubMed ID: 34548096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]